Showing 1 - 10 of 158
Persistent link: https://www.econbiz.de/10008701491
Persistent link: https://www.econbiz.de/10010485559
Persistent link: https://www.econbiz.de/10011409439
Persistent link: https://www.econbiz.de/10001493650
Persistent link: https://www.econbiz.de/10001146834
Persistent link: https://www.econbiz.de/10000920438
Persistent link: https://www.econbiz.de/10001322683
In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important federal legislation, institutional details regarding distribution channel logistics, definitions of alternative price measures, related historical...
Persistent link: https://www.econbiz.de/10013139118
We establish four facts concerning competition among U.S. generic drug suppliers, using IQVIA's National Sales Perspective™ 2004Q4 - 2016Q3 data. We define a unique product market ("molform"), consisting of the combination of a molecule active ingredient and a route of administration...
Persistent link: https://www.econbiz.de/10012480138
In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important federal legislation, institutional details regarding distribution channel logistics, definitions of alternative price measures, related historical...
Persistent link: https://www.econbiz.de/10012462361